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A B S T R A C T
Predicting adult height from DNA has important implications in forensic DNA phenotyping. In 2014, we in-
troduced a prediction model consisting of 180 height-associated SNPs based on data from 10,361 Northwestern
Europeans enriched with tall individuals (770 > 1.88 standard deviation), which yielded a mid-ranged accu-
racy (AUC=0.75 for binary prediction of tall stature and R2= 0.12 for quantitative prediction of adult height).
Here, we provide an update on DNA-based height predictability considering an enlarged list of subsequently-
published height-associated SNPs using data from the same set of 10,361 Europeans. A prediction model based
on the full set of 689 SNPs showed an improved accuracy relative to previous models for both tall stature
(AUC=0.79) and quantitative height (R2= 0.21). A feature selection analysis revealed a subset of 412 most
informative SNPs while the corresponding prediction model retained most of the accuracy (AUC=0.76 and
R2= 0.19) achieved with the full model. Over all, our study empirically exempliﬁes that the accuracy for
predicting human appearance phenotypes with very complex underlying genetic architectures, such as adult
height, can be improved by increasing the number of phenotype-associated DNA variants. Our work also de-
monstrates that a careful sub-selection allows for a considerable reduction of the number of DNA predictors that
achieve similar prediction accuracy as provided by the full set. This is forensically relevant due to restrictions in
the number of SNPs simultaneously analyzable with forensically suitable DNA technologies in the current days of
targeted massively parallel sequencing in forensic genetics.
1. Introduction
Forensic DNA Phenotyping (FDP) [1] is a fast-developing subﬁeld of
forensic genetics aiming at inferring externally visible information
(appearance, bio-geographic ancestry, and chronological age) of an
unknown crime scene sample donor directly from DNA. Such in-
formation can assist police investigations in ﬁnding unknown perpe-
trators of crime in cases where the standard forensic STR-proﬁling is
non-informative due to the lack of known suspects. So far, the most
successful FDP examples are restricted to human pigmentation traits,
which is explained by the presence of major gene eﬀects, so that
statistical models consisting of a limited number of SNPs can provide
highly accurate prediction results [2–4]. Because SNPs with larger ef-
fects are easier to identify in gene mapping studies, and prediction tools
based on a limited number of SNPs can easily be developed, FDP sys-
tems for eye, hair and skin colour prediction from trace DNA have al-
ready been developed and forensically validated [5,6]
Widening appearance DNA prediction beyond pigmentation traits is
generally troubled by the absence of major gene eﬀects in non-pig-
mentation appearance traits, thus requiring a much larger number of
DNA predictors due to their small phenotypic eﬀects [7–9]. Recent
progress illustrated, as is theoretically expected, that when genome-
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wide association studies (GWASs) based on increased sample size are
applied for appearance traits, larger numbers of genome-wide sig-
niﬁcant SNPs with small eﬀects are found, such as shown for hair
structure [7], hairloss in men [8,10], hair colour [11], and skin colour
[12]. Moreover, it has been demonstrated recently for hair structure
[13], hairloss in men [10], and hair colour [11] that when the enlarged
numbers of identiﬁed SNPs are applied in prediction studies, they
provide increased prediction accuracies compared to earlier models
based on fewer numbers of SNPs [14,15]. However, for having suﬃ-
cient statistical power to identify large numbers of associated SNPs with
small eﬀects, GWAS meta-analyses with very large combined sample
size are required, which until recently were not available for any ap-
pearance traits, with the notable exception of adult height.
Adult height is characterized by a high degree of heritability esti-
mated at about 80% [16–18], while its inheritance is clearly non-
Mendelian, and thus height is considered as a model trait in human
complex trait genetics [19–21]. To date, four sizable GWAS meta-ana-
lyses on adult height with increasing sample size have been conducted
by the international Genetic Investigation of Anthropometric Traits
(GIANT) Consortium [22–25]. These studies have demonstrated that
the genetic complexity of adult height is extremely high, involving
many hundreds and expectedly thousands of independently con-
tributing genetic loci characterized by common SNPs with small to very
small phenotypic height eﬀects [22,23,25], in addition to a smaller
number of rare SNPs with somewhat larger eﬀects [24].
In 2014, based on all height-associated SNPs known at that time, we
reported a height prediction study [26] and described the performance
of a prediction model consisting of 180 height-associated SNPs pre-
viously identiﬁed by the ﬁrst GIANT height GWAS meta-analysis con-
sisting of 183,727 Europeans [22]. This model provided a prediction
accuracy expressed by the area under the receiver operating char-
acteristic curve (AUC) of 0.75 (95% CI 0.72-0.79) for binary tall stature
prediction and R2 of 0.12 (95% CI 0.10-0.14) for quantitative (full-
range) height prediction [26], which substantially surpassed a previous
model based on 54 earlier-identiﬁed, height-associated SNPs with an
AUC of 0.65 [21]. In parallel, the second GWAS meta-analysis was
published by the GIANT Consortium in 2014 based on a largely in-
creased sample size consisting of 253,228 Europeans, which identiﬁed
697 independently contributing genetic loci [23]. In the present study,
we use these 697 genome-wide height associated SNPs to update the
capacity of DNA-based predictability of adult height employing the
same set of 10,361 Dutch Europeans we used earlier [26].
2. Materials and methods
2.1. The Dutch tall stature cohort
From the records of the Division of Pediatric endocrinology at the
Erasmus University Medical Center, Sophia Children’s Hospital, we
identiﬁed former patients who attended this clinic for evaluation of tall
stature. Eligible subjects were traced using municipal registries and
invited by mail to participate in this study. The height of all participants
were above +1.88 standard deviation score (SDs) according to Dutch
standards (http://www.tno.nl/groei), which corresponds to the 3%
upper tail of the height distribution in Dutch adults, approximately>
195 cm in men and>180 cm in women at age 30, after correcting for
secular trend [26]. Details regarding the inclusion criteria, height
phenotyping, microarray genotyping, SNP imputation and quality
controls have been described in our previous study [26]. After all
genomic and phenotypic quality controls, the current study included
462 unrelated Dutch tall individuals. The Dutch tall stature study has
been approved by the Medical Ethics Committee of the Erasmus MC
(registration number MEC-2005-091) and all study participants pro-
vided written informed consent.
2.2. The Rotterdam study (RS)
The Rotterdam Study is a prospective cohort study ongoing since
1990 in the city of Rotterdam in The Netherlands [27]. Details re-
garding the height phenotyping, microarray genotyping, SNP imputa-
tion and quality controls have been described in our previous study
[26]. After genomic and phenotypic quality controls, the current study
included 9,899 participants from the RS. The tall stature was set as the
sex and age adjusted residuals> 1.88 standard deviations (308 tall
individuals). After merging with the Dutch tall individuals, the current
study includes a total of 10,361 individuals, comprising 770 tall
(> 1.88 standard deviation) and 9,591 normal-height individuals, and
2,530,557 autosomal SNPs.
The Rotterdam Study has been approved by the Medical Ethics
Committee of the Erasmus MC (registration number MEC 02.1015) and
by the Dutch Ministry of Health, Welfare and Sport (Population
Screening Act WBO, license number 1071272-159521-PG) and all study
participants provided written informed consent. The Rotterdam Study
has been entered into the Netherlands National Trial Register (NTR;
www.trialregister.nl) and into the WHO International Clinical Trials
Registry Platform (ICTRP; www.who.int/ictrp/network/primary/en/)
under shared catalogue number NTR6831.
The Rotterdam samples used here represent a small fraction (3.9%)
of the samples used for discovery purposes by Wood et al. [23], whereas
the Dutch tall cohort samples are completely independent from those
used by Wood et al. [23].
2.3. Statistical analyses
Sex and age adjusted height residuals were considered as a quan-
titative phenotype and the individuals with height residuals greater
than 1.88 standard deviations were considered as tall stature. The
height residuals, ԑ, were derived using linear regression, i.e.,
= + +height sex age ε. We calculated the polygenic scores (also called
weighted allele sums) for all individuals according to their genotypes of
the 689 height associated SNPs that survived quality control and the
regression beta values reported by Wood et al. [23]. The polygenic score
was used to ﬁt linear models for quantitative height prediction and
logistic models for binary tall stature prediction in a randomly selected
80% training sample. Then we applied the models to predict quanti-
tative height and binary tall stature in the remaining 20% testing
sample, repeated for 1,000 replicates, and estimated the mean accuracy
parameters and the 5%–95% boundary values. For quantitative pre-
diction the accuracy parameters included R2 and mean absolute error
(MAE). An R2 value equals to the square of the correlation (r) between
the predicted and observed values, which corresponds the proportion of
the sex and age adjusted height residual variance explained by the SNP




1 , where yi is the predicted and xi is the
observed value for a given sample. For binary prediction the accuracy
parameters included the Area Under the Receiver Operating Char-
acteristic (ROC) Curves, or AUC, Sensitivity, Speciﬁcity, Positive Pre-
dictive Value (PPV), and Negative Predictive Value (NPV). The AUC is
the integral of ROC curves as an overall estimate of the prediction ac-
curacy for a binary classiﬁer, ranging from 0.5 representing total lack of
prediction to 1.0 representing completely accurate prediction. Sensi-
tivity, speciﬁcity, PPV, and NPV were derived from a 2 by 2 confusion
table consisting of the numbers of true positives, true negatives, false
positives and false negatives according to standard formulas where a
‘positive’ prediction was deﬁned using the predicted probability> 0.5.
Due to technical needs in forensic genetics to keep the number of
DNA markers at a minimum so that at best they can be analyzed si-
multaneously, we conducted a feature selection analysis in the training
set to reselect a subset of the most tall stature-informative SNPs.
Backward stepwise logistic regression analysis was conducted ac-
cording rank of the Akaike Information Criterion (AIC),
+ ∑ −=k n y E yAIC˜2 ln( ( ( )) )i
n
i i1
2 , where k is the number of SNPs, n is
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the sample size, and E y( )i is the ﬁtted value. The SNP set with the
minimal AIC value was considered as the theoretically optimal subset
for prediction. This SNP subset was then used to construct linear and
logistic models and to predict quantitative height and binary tall stature
in the testing set.
3. Results
Among the 697 independent genome-wide signiﬁcant height-asso-
ciated SNPs reported by Wood et al. [23], 689 passed quality control in
our study. Among these, 634 SNPs (92.0%) had allele eﬀects on the
same direction as reported by Wood et al., 308 SNPs (44.7%) showed
nominally signiﬁcant association (p < 0.05) with quantitative height
and 178 SNPs (25.8%) showed nominally signiﬁcant association
(p < 0.05) with binary tall stature in our dataset (Table S1). The
polygenic scores derived using the 689 SNPs and the regression betas
from Wood et al. [23] showed signiﬁcant positive correlations with sex
and age adjusted height residuals (r=0.46, p< 1×10−300), and
showed a signiﬁcant increase from non-tall (mean=0.41) to tall in-
dividuals (mean=0.94, p<1×10−300, Fig. 1A).
To provide the null distribution of the prediction results, we ran-
domly selected 689 SNPs over the genome, estimated their eﬀects
(linear regression beta) in the training set, constructed polygenic scores,
built linear and logistic models, and predicted binary tall stature and
quantitative height in the testing set. This set of random 689 SNPs
provided a mean AUC value of 0.53, a mean R2 of 0.001, and a mean
MAE of 9.56 cm after 1000 replicates (Table 1). These estimates were
close to the expected values under the null hypothesis of no predictive
power, and were similar to our previous estimates using the 180 ran-
domly selected SNPs [26] (Table 1). In other words, 689 SNPs randomly
selected from the genome provided no predictive value for tall stature
and for quantitative height, as may be expected.
In contrast, the performance of the models using the 689 height-
associated SNPs and the regression betas reported by Wood et al. [23]
showed fairly accurate prediction for tall stature (AUC=0.79, 95% CI:
0.75-0.82, Table S2) and also demonstrated prediction for quantitative
height (R2= 0.21, 95% CI: 0.18-0.24, MAE =5.00 cm, 95% CI:
4.85–5.16, Table 1). Notably, these estimates were improved compared
to our previous models based on the 180 height-associated SNPs iden-
tiﬁed by Lango Allen et al. [22] (AUC=0.75, 95% CI: 0.72-0.79;
R2= 0.12, 95% CI: 0.10-0.14; MAE =5.25 cm, 95% CI: 5.07–5.41,
Table 1).
Next, we tested for the trade-oﬀ between the number of predictive
DNA markers and the model performance. At this end, we conducted a
feature selection analysis using stepwise logistic regression in the
training set, and ranked all SNPs according to their contribution to the
model performance (Fig. 1B). From this analysis, a model consisting of
412 SNPs is proposed as the best-ﬁtting model with the minimal AIC
value (Fig. 1B). When applied in the testing set, this 412-SNP model
achieved decreased prediction accuracies compared to the full 689-SNP
model (AUC=0.76, 95% CI: 0.73-0.80; R2= 0.19, 95% CI: 0.17-0.22;
MAE =5.09 cm, 95% CI: 4.93–5.31, Table 1, Table S2), while most of
Fig. 1. (A) Density plot of polygenic scores in 770 tall and 9,591 non-tall Dutch Europeans. (B). Relationship between number of SNP predictors and prediction
accuracy for binary tall stature prediction in 770 tall and 9,591 non-tall Dutch Europeans. The dashed red line marks the cut-oﬀ at 412 SNPs we used as best-ﬁt
model, because further increasing the number of SNP predictors in the model did not result in increased AUC values (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article).
Table 1
Accuracy for predicting tall stature and quantitative adult height using diﬀerent SNPs sets in 10,361 Dutch Europeans.
Binary tall stature prediction Quantitative height prediction
SNP list N AUC L95 U95 Sens Spec NPV PPV R2 L95 U95 MAE L95 U95
Random set 180 0.52 0.48 0.55 1.00 0.00 0.00 0.93 0.00 0.00 0.01 9.54 5.45 84.20
Random set 689 0.53 0.47 0.58 0.73 0.53 0.65 0.65 0.00 0.00 0.00 9.56 5.49 49.47
Lango Allen et al. 2010 180 0.75 0.72 0.99 0.01 0.76 0.33 0.93 0.12 0.10 0.14 5.25 5.07 5.41
Wood et al. 2014 689 0.79 0.75 0.98 0.01 0.74 0.55 0.93 0.21 0.18 0.24 5.00 4.85 5.16
Feature selection from Wood et al. 2014 412 0.76 0.73 0.99 0.03 0.69 0.15 0.93 0.19 0.17 0.22 5.09 4.93 5.31
N: number of SNPs used in the model; AUC: the Area Under the Receiver Operating Characteristic Curves; Sens: Sensitivity; Spec: Speciﬁcity: NPV: Negative
Predictive Value: PPV: Positive Predictive Value; MAE: mean absolute error; L95 and U95: the 95% lower and upper boundary values from 1000 replicates of 80%-
20% cross-validations.
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the prediction accuracy provided by the full model was retained with
this reduced model.
4. Discussion
Although adult height is characterized by high heritability [28,29],
the genetic architecture of stature is extremely complex without clear
major gene eﬀects [22–25]. This biological situation provides major
challenges to the DNA-based prediction of adult height as being re-
levant in FDP. Our study demonstrated that DNA-based height predic-
tion for both tall stature and continuous height can be improved by
increasing the number of DNA predictors from 180 SNPs, as we applied
previously [26], to 689 SNPs as tested here. The model we introduce
here based on 689 SNPs achieves the highest currently available pre-
diction accuracy for tall stature.
However, analyzing the full set of 689 SNPs in low quality and low
quantity DNA samples available from compromised crime scene mate-
rial, as often confronted with in forensic DNA testing, is technically
challenging. Therefore, we attempted to reduce the number of SNP
predictors by maximizing the prediction accuracy, which resulted in a
best-ﬁtted model based on 412 (60%) SNPs achieving a similar accu-
racy as the full set of 689 SNPs. From a forensic genetics perspective it
would be desirable to establish an even smaller set achieving similarly
high prediction accuracy; however, our ﬁndings demonstrate (see
Fig. 1B) that the genetic complexity of adult height does not allow this
without losing more prediction accuracy, not even for tall stature pre-
diction. Nevertheless, our study demonstrates that the level of accuracy
improvement as shown here brings DNA-based prediction of tall stature
closer to practical forensic applications. For comparison, AUC values
achieved with the HIrisPlex system, which has already been used in
anthropological applications and forensic casework, range from 0.74 to
0.95 for eye colour and from 0.75 to 0.92 for hair colour [30].
Recently, Marouli et al. [24] performed an adult height GWAS based
on whole exome sequencing (WES) data in 711,428 Europeans, and
reported 83 height-associated coding variants with low minor allele
frequencies but increased eﬀect size. Of these, only 7 passed the quality
control in our microarray-based study, of which one was already in-
cluded in the 697 SNPs we tested. Of the 6 remaining SNPs, none
showed signiﬁcant association with height in our data (P > .05). With
the exception of one, we therefore could not include the SNPs high-
lighted by Marouli et al. in our study. In principle, the suitability of
including rare DNA variants with increased eﬀect size in a prediction
model depends not only on the minor allele frequency and thus the
chance to observe the predictive minor allele in a newly tested DNA
sample, but also the number of such rare DNA predictors being avail-
able, which has to be large to increase the chance that at least some will
be present with their predictive minor allele in the tested DNA sample.
More height GWASs based on WES and whole genome sequencing
(WGS) data need to be carried out in the future to identify more rare
SNPs with increased height eﬀects, to be tested in prediction modelling
studies together with common height SNPs.
Theoretically, it is expected that using more than the 689 SNPs
height-informative DNA markers we tested here in the prediction
modeling will yield to higher prediction accuracy outcomes. However,
because there is no linear relationship between the number of DNA
predictors and the prediction accuracy, this needs to be empirically
tested. Very recently in August 2018, Yengo et al. [25] published the
third GWAS meta-analysis on height of the GIANT Consortium based on
693,529 Europeans, which highlighted 512 new height-associated loci
not previously identiﬁed in the second GIANT height GWAS by Wood
et al [23] we considered here. Unfortunately, due to the timing of our
study, we were unable to include these new loci in our current pre-
diction analyses, which shall be done in future studies.
Prior to the time of the advent of targeted MPS technologies in
forensic genetics, any consideration of hundreds of SNPs for crime
scene DNA analysis would have been technically impossible due to the
limited multiplex capacity of the previously used SNP genotyping
technologies that are suitable to low quality and low quantity DNA,
which typically does not allow reliable use of SNP microarrays. Recent
studies demonstrated that targeted MPS allows the simultaneous ana-
lysis of some hundreds of SNPs [31,32] and meets the requirements for
forensic DNA analysis [33,34]. Forensic applications of 20,000 SNPs for
genomic prediction of adult height [35] is currently not possible with
targeted MPS and is irrelevant for many forensic cases where the low
DNA quality and quantity does not allow the application of SNP mi-
croarrays. With the availability of targeted MPS technologies and their
demonstrated suitability for forensic DNA analysis, appearance pre-
diction models involving hundreds of SNPs, as demonstrated here for
tall stature, are now becoming feasible for forensic genetics in general
and Forensic DNA Phenotyping in particular.
Besides the technical problems related to DNA quality and quantity,
it is generally preferred in forensic genetics to use targeted DNA over
the non-targeted DNA technologies because in many countries forensic
DNA analysis is regulated by law and restricted to certain uses of DNA.
Non-targeted genomic screening technologies, such as SNP microarray
analysis or whole genome sequencing analysis, may deliver far more
genetic information than what forensic geneticists are legally allowed
to have in many countries. It may be expected that with the current fast-
pace developments in targeted MPS technologies, technical solutions to
simultaneously genotype thousands of SNPs with high accuracy and
sensitivity from DNA with low quality and quantity, thereby fulﬁlling
requirements of forensic DNA analysis, may become available in the
future, which will boost the genomic prediction of human complex
appearance phenotypes including adult height and more. A promising
technological development is targeted capture sequencing [36] which is
widely used for whole exome sequencing [37] in genetic epidemiology
studies and has been introduced to the ﬁeld of ancient DNA for ana-
lysing hundreds of thousands of SNPs [38] Targeted enrichment using
probe capture has been introduced to forensic DNA analysis for whole
mitogenome sequencing and sequencing of hundreds of SNPs [39]
while forensic applications of targeted capture sequencing thousands of
SNPs are pending as of yet.
5. Conclusion
By providing an update on the DNA predictability of tall stature in
Europeans we introduce a prediction model consisting of 689 height-
associated SNPs that achieved AUC of 0.79. Given the forensic need to
reduce the number of SNP predictors while maximizing the prediction
accuracy, we demonstrated that a subset of 412 SNPs achieved similar
prediction accuracy with AUC of 0.76. To further increase prediction
accuracy of tall stature, and especially for the full range of adult height,
many more independently contributing SNP predictors are needed to-
gether with forensically suitable DNA technologies for their simulta-
neous analysis from crime scene stains.
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